PMID: 11919245Mar 29, 2002Paper

Phase II study of paclitaxel plus gemcitabine in refractory germ cell tumors (E9897): a trial of the Eastern Cooperative Oncology Group

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Stuart HintonGeorge Wilding

Abstract

Despite great success in the treatment of disseminated germ cell tumors, 20% of patients are incurable and become candidates for investigational therapy. Paclitaxel and gemcitabine have shown activity as single agents in refractory germ cell tumors and can be combined with manageable toxicity. Patients with germ cell tumors believed to be incurable with chemotherapy or surgery were treated with paclitaxel 110 mg/m(2) and gemcitabine 1,000 mg/m(2) intravenously on days 1, 8, and 15 of a 4-week cycle for a maximum of six cycles. Patients were evaluated for response and toxicity. Twenty-eight of 30 enrolled patients were assessable. Toxicity was primarily hematologic but was manageable with only a single case of neutropenic fever. Six (21.4%) of 28 patients responded, including three complete responses. Two of the complete responders were continuously disease-free at 15+ and 25+ months. Paclitaxel plus gemcitabine is an active regimen in refractory germ cell tumors, with an acceptable toxicity profile. This regimen has the possibility for long-term disease-free survival in this refractory patient population.

References

Jun 4, 1987·The New England Journal of Medicine·S D WilliamsP J Loehrer
Jul 1, 1989·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C R NicholsS N Wolff
Mar 1, 1989·Controlled Clinical Trials·R Simon
Nov 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R J MotzerP Fischer
Jan 1, 1996·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C BokemeyerH J Schmoll
Jul 24, 1997·The New England Journal of Medicine·G J Bosl, R J Motzer
Jul 17, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P J LoehrerL H Einhorn
Mar 18, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·L H EinhornS D Williams
Mar 18, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C BokemeyerL Kanz
Mar 15, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R J MotzerG J Bosl
Mar 15, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P PorcuL H Einhorn
Jun 16, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R J MotzerG J Bosl
Oct 3, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S BhatiaL H Einhorn
Sep 1, 1995·Urologic Oncology·A NazarioC J Logothetis

❮ Previous
Next ❯

Citations

Dec 10, 2003·The Lancet Oncology·Robert H Jones, Paul A Vasey
Nov 15, 2003·Best Practice & Research. Clinical Obstetrics & Gynaecology·E S Newlands
Jun 5, 2003·Current Opinion in Oncology·Beth A Hellerstedt, Kenneth J Pienta
Feb 8, 2006·American Journal of Clinical Oncology·Lawrence H EinhornAli Madani
Apr 17, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C KollmannsbergerC Bokemeyer
Jun 11, 2010·Indian Journal of Urology : IJU : Journal of the Urological Society of India·Emma J AlexanderAlan Horwich
Jun 16, 2011·Urology Annals·Mohammed Al OtaibiHussein Al Kushi
Mar 22, 2014·International Journal of Clinical Oncology·Masahiro UchidaHiroyuki Nishiyama
Oct 30, 2003·Critical Reviews in Clinical Laboratory Sciences·Finn Edler von Eyben
May 17, 2011·Hematology/oncology Clinics of North America·Christine M Veenstra, David J Vaughn
Mar 1, 2011·Gynecologic Oncology·C A ParkinsonT V Ajithkumar
Aug 21, 2007·International Journal of Radiation Oncology, Biology, Physics·Jose M AzarLawrence H Einhorn
Aug 15, 2006·International Journal of Urology : Official Journal of the Japanese Urological Association·Isao HaraMasato Fujisawa
Apr 10, 2010·International Journal of Urology : Official Journal of the Japanese Urological Association·Terukazu Nakamura, Tsuneharu Miki
Jan 22, 2005·Critical Reviews in Oncology/hematology·Stefania GoriMaurizio Marangolo
Mar 7, 2006·Lancet·Alan HorwichRobert Huddart
Oct 22, 2005·Clinical Oncology : a Journal of the Royal College of Radiologists·B Sirohi, R Huddart
Dec 30, 2014·Andrology·C Jacobsen, F Honecker
Aug 20, 2008·Expert Opinion on Pharmacotherapy·C KollmannsbergerC Bokemeyer
Oct 14, 2014·Urologic Oncology·Brent O'Carrigan, Peter Grimison
May 21, 2014·Journal of the Egyptian National Cancer Institute·Magdy M SaberManar Monir
Mar 24, 2009·European Urology·Roisin M Connolly, John A McCaffrey
Feb 10, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lawrence H EinhornStephen D Williams
May 14, 2016·Journal of Oncology Practice·Sawsan Rashdan, Lawrence H Einhorn
Feb 19, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jinxing LiChristopher J Sweeney
Jan 1, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C KollmannsbergerC Bokemeyer
Dec 1, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Pablo M BedanoLawrence H Einhorn
Dec 13, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G Varuni Kondagunta, Robert J Motzer
Oct 14, 2005·Expert Review of Anticancer Therapy·Marcus L QuekDonald G Skinner
Feb 8, 2006·Cancer·Christian KollmannsbergerCarsten Bokemeyer
Mar 11, 2005·Expert Review of Anticancer Therapy·Robert A Huddart, Alison J Birtle
Oct 21, 2009·BJU International·Gedske Daugaard

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Christian KollmannsbergerCarsten Bokemeyer
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Christian KollmannsbergerCarsten Bokemeyer
Annals of Oncology : Official Journal of the European Society for Medical Oncology
D PectasidesD Skarlos
Annals of Oncology : Official Journal of the European Society for Medical Oncology
Carsten BokemeyerH-J Schmoll
© 2022 Meta ULC. All rights reserved